Blood Biomarkers
8
1
2
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 8 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (8)
AI for Lung Cancer Risk Definition in Computed Tomography Screening Programs
Cognicise Training for Seniors for Healthy Aging
Ultrasound of the Spleen Utilizing Low-energy (Diagnostic Level) Insonification.
Delivering Transcutaneous Auricular Neurostimulation to Regulate Platelet Activity in Healthy Human Subjects
Blood Biomarkers in Electroconvulsive Therapy
Blood Biomarkers for Screening of Alzheimer's Disease
The Role of Eicosanoids in the Cardiovascular Actions of Inhaled Nanoparticles
EndoSearch : Endometriosis Biomarkers